- HMRC has extended VAT zero-rating for drugs and medicines dispensed in accordance with a patient group direction.
- The change applies for drugs and medicines supplied between 9 October 2023 and 31 March 2027.
- The VAT treatment is being updated to reflect the way healthcare professionals supply drugs and medicines to patients.
- A patient group direction allows for the provision of specified drugs to a pre-defined group of patients without prescription.
- The order brings the treatment of these supplies in line with the VAT treatment of drugs dispensed on prescription to individual patients.
Source: taxjournal.com
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "United Kingdom"
- HMRC Technical Manuals: Guidance for Staff and Tax Professionals with Legal and Interpretative Updates
- UK Reverses Skandia VAT Grouping Rules: Overseas Branches No Longer Separate Taxable Persons
- Key Steps and Common Errors in Postponed VAT Accounting for UK Importers
- Tribunal Upholds Strict Evidence Requirement for Input VAT Recovery in Dreyer Case
- Express Brands Ltd: Tribunal Rules Company as Principal, Liable for Full VAT on Retail Sales
